ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ALIM Alimera Sciences Inc

2.96
0.04 (1.37%)
2024年6月8日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Alimera Sciences Inc ALIM NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.04 1.37% 2.96 09:00:00
始値 安値 高値 終値 前日終値
2.92 2.92 3.04 3.01 2.92
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/0505:30GLOBEAlimera Sciences Reports Inducement Grants Under Nasdaq..
2024/5/1706:06EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/5/1506:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1421:46EDGAR2Form 8-K - Current report
2024/5/1420:30GLOBEAlimera Sciences Reports First Quarter 2024 Results
2024/5/0721:00GLOBEAlimera Announces Scientific Data Highlighting YUTIQ® to be..
2024/4/3021:00GLOBEAlimera Sciences to Report First Quarter 2024 Financial..
2024/3/2021:00GLOBEAlimera Sciences Reports Inducement Grants Under Nasdaq..
2024/3/1921:00GLOBEAlimera Announces First Patient Randomized in Radiation..
2024/3/0907:23EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0722:32EDGAR2Form 8-K - Current report
2024/3/0721:30GLOBEAlimera Sciences Reports Fourth Quarter and Full Year 2023..
2024/2/2922:00GLOBEAlimera Sciences to Report Fourth Quarter and Full Year 2023..
2024/2/1406:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1406:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1405:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1007:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/1007:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/1007:08EDGAR2Form 8-K - Current report
2024/2/0822:00GLOBEThe UK National Institute for Health and Care Excellence..
2024/1/1202:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0506:01EDGAR2Form 8-K - Current report
2024/1/0422:00GLOBEAlimera Completes Recruitment for the Synchronicity Study
2024/1/0222:00GLOBEAlimera Sciences Names Elliot Maltz as Chief Financial..
2023/12/1407:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1307:09EDGAR2Form 8-K - Current report
2023/12/1221:30GLOBEAlimera Sciences Appoints Todd Wood as President of U.S...
2023/11/2906:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2906:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2906:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0908:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0907:18EDGAR2Form 8-K - Current report
2023/11/0906:30GLOBEAlimera Appoints Maggie A. Pax to Its Board of Directors
2023/10/3121:00GLOBEAlimera Announces Scientific Data Highlighting ILUVIEN® To..
2023/10/2620:39EDGAR2Form 8-K - Current report
2023/10/2620:00GLOBEAlimera Sciences Reports Third Quarter 2023 Results
2023/10/1621:00GLOBEAlimera Sciences to Report Third Quarter 2023 Financial..
2023/10/1121:00GLOBEAlimera Announces Multiple Presentations Highlighting..
2023/10/0506:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0505:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0505:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0505:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0505:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0505:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0505:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0321:00GLOBEAlimera Sciences Appoints Jason Werner as Chief Operating..
2023/10/0320:00EDGAR2Form 8-K - Current report
2023/9/1605:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock